| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |